It should be noted that a measure of the total HER2 protein levels with a monoclonal antibody basically mirrors the variations in full-length HER2, but gives no information on Delta16 expression, thus suggesting that only an assessment of HER2 isoforms could provide a reliable estimate of the functionally relevant oncoproteins in human breast cancer. This evidence concerns the gene ERBB2 and breast cancer.